Yoga for lung functions in COVID-19 survivors
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/09/036829
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a)Known case of COVID patients with respiratory symptoms on screening (RT-PCR negative or 4 weeks to 8 weeks from the onset of first symptom)
b)Patients with forced vital capacity(FVC) <80%
c)Patients of both sex and age of18-75years
d)Patients who are able and willing to practice any form of exercise when recruited under the study
e)Patients who are not engaged in regular and structured yoga practice.
a)Patients with forced vital capacity FVC <40 %
b)Previous pulmonary complications like severe asthma, COPD, bronchiectasis, interstitial lung disease(IL)
c)Known cases of CAD with moderate to severe LV dysfunction, patients with a history of CV or neurodegenerative diseases.
d)Lactating and pregnant women.
e)Patients currently participating in any other clinical trials with intervention.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary Function: Diffusion lung capacity for carbon monoxide (DLCO), Forced Vital capacity (FVC), Forced expiratory volume in first second (FEV1), Total lung capacity (TLC) using Pulmonary function testTimepoint: Baseline, after 6 weeks and at the end of 12 weeks
- Secondary Outcome Measures
Name Time Method Severity of dyspnea using UCSD Shortness of Breath Questionnaire. <br/ ><br>Exercise capacity using 6-minute walk test <br/ ><br>Inflammatory markers such as Interleukin-6(IL-6) and C-reactive protein (CRP). <br/ ><br>Total severity score, presence of significant extension of fibrotic abnormalities, ground glass <br/ ><br>Opacities (GGO) and consolidation, lobar distribution and linear opacities using HRCT of lungs Psychological assessment using general Anxiety Disorder-7(GAD-7), Patient Health Questionaire9 (PHQ-9) <br/ ><br>Health related quality of life (QOL) using short form (SF-36)Timepoint: Baseline, after 6 weeks and at the end of 12 weeks